Keningford Partners
Business news and market analysis

News & Insights

The latest from Keningford Partners.

Perspectives on capital markets, transactions, and firm developments — drawn from live mandate activity across equity, debt, and M&A.

Keningford Partners publishes in-depth perspectives on the trends shaping how growth-stage companies raise capital and transact. Our coverage draws on activity across the sectors we advise — equity, debt, and strategic M&A — so founders, boards, and investors can see where capital is moving, not just where headlines point. For institutional and professional use only.

EnergyCite engineering and research team collaborating in the lab
EnergyCite Inc. logo
Transactions

Advising EnergyCite on Its Current Capital Raise

Keningford Partners is advising EnergyCite on its current capital raise. Founded by the inventor of the smart utility meter, EnergyCite is commercializing an AI-powered conservation app that gives residential customers real-time visibility into usage, rates, and monthly spend.

Read more
Sustainable biotechnology research laboratory
EcoPha Biotech logo
Transactions

Advising EcoPha Biotech on Its Current Capital Raise

Keningford Partners is advising EcoPha Biotech on its current capital raise. The company is developing sustainable bioplastics and aviation fuel from a single non-edible feedstock — a dual-output platform anchored by a Queensland flagship project with government co-funding and strategic partnerships across aviation and industrial sectors.

Read more
Technology platform and enterprise software infrastructure
Market Insights

Vertical AI Capital Trajectory: What H2 2026 Looks Like for Growth Rounds

Vertical AI has become one of the most contested growth-stage capital destinations. Investors are paying for workflow depth, retention, and defensible data — not model wrappers.

Read more
Healthcare technology and clinical workflow systems
Market Insights

Healthcare AI Equity: What Growth-Stage Round Data Actually Shows

Healthcare AI rounds in 2025–2026 closed at premium multiples relative to horizontal software — but only for assets with reimbursement clarity, clinical validation, and enterprise distribution.

Read more
Private wealth and institutional investment discussion
Market Insights

Family Office Allocation Shift: H2 2026 Watch

Family offices are redeploying toward direct investments, co-investments, and structured equity — with longer hold periods and sharper governance expectations than the prior cycle.

Read more
Founder reviewing capital structure and financing documents
Market Insights

The Debt-First Capital Stack: A Founder's Toolkit

When equity is expensive, growth-stage founders are rebuilding the capital stack with venture debt, structured credit, and hybrid instruments, without defaulting to dilution.

Read more
Founders and board members reviewing shareholder liquidity options
Market Insights

Founder Liquidity Without IPO: Secondary Tender Structures

As the median time from Series A to IPO stretches past a decade, secondary tenders and structured liquidity programs have become a core tool for retention — not a sign of weakness.

Read more
Executive team evaluating capital structure alternatives
Market Insights

The Down-Round Playbook: Structural Options for Founders in 2026

Down rounds are no longer exceptional. Founders facing a reset should compare four structural paths — and three questions — before signing terms.

Read more
Market data and capital markets analysis on a desk
Market Insights

Q2 2026 Lower Middle Market Capital Outlook

Credit conditions, equity selectivity, and process length are reshaping how lower middle-market companies access institutional capital in the second half of 2026.

Read more
Founders and advisors planning an equity fundraising timeline
Market Insights

The 14-Week Growth-Round Cycle: What Changed for Founders

Institutional growth equity processes have lengthened. Founders should treat fourteen weeks as the operational base case, and prepare runway accordingly.

Read more
Stock market trading screens and financial data
Market Insights

Capital Markets Outlook for 2026

After two years of repricing across rates, credit spreads, and equity multiples, issuers and sponsors are entering 2026 with clearer visibility, but capital providers are demanding more on quality, governance, and use of proceeds.

Read more
Glass skyscrapers in the New York financial district
Firm News

Keningford Partners Launches as Boutique Capital Advisory and M&A Firm in New York

Keningford Partners has officially launched in New York, led by Founder and Managing Partner Tuna Yilar, with a principal-led model focused on capital raises, M&A advisory, and debt advisory from Series A through pre-IPO.

Read more
Corporate executives reviewing transaction documents
Transactions

Keningford Partners Advises on $150 Million Growth Equity Financing

Keningford Partners served as exclusive financial advisor to a vertical software platform in a $150 million growth equity round led by a North American institutional syndicate.

Read more
Modern hospital corridor and healthcare facility
Market Insights

Strategic M&A Activity Accelerates in Healthcare Services

Deal volume in outpatient, behavioral health, and physician services remains elevated, but valuation dispersion between market leaders and the broader field has rarely been wider.

Read more
Manhattan financial district skyline at dusk
Firm News

Keningford Partners Expands Senior Advisory Team

The firm has appointed three Managing Directors across M&A, capital raising, and restructuring advisory, extending senior coverage in technology, healthcare, and industrials.

Read more